XML 57 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details)
1 Months Ended 12 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Nov. 30, 2019
$ / shares
shares
Dec. 31, 2021
USD ($)
operating_segment
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
shares
Jul. 31, 2021
$ / shares
Summary Of Significant Accounting Policies [Line Items]              
Impairment of long lived assets       $ 0 $ 0 $ 0  
Number of operating segments | operating_segment       1      
Equity method investments       $ 0      
Common Shares              
Summary Of Significant Accounting Policies [Line Items]              
Issuance of common stock, net (in shares) | shares   6,571,428 5,227,273 3,500,000 6,600,000 6,600,000  
Share price, issued and sold (in dollars per share) | $ / shares   $ 70.00 $ 22.00   $ 70.00    
Stock Purchase Agreement | Pfizer, Inc. | Common Shares              
Summary Of Significant Accounting Policies [Line Items]              
Issuance of common stock, net (in shares) | shares 3,457,815            
Share price, issued and sold (in dollars per share) | $ / shares $ 101.22           $ 101.22
Aggregate purchase price $ 350,000,000            
Stock Purchase Agreement | Pfizer, Inc. | Fair Value, Nonrecurring | Common Shares              
Summary Of Significant Accounting Policies [Line Items]              
Issuance of common stock, net (in shares) | shares       3,457,815      
Oerth              
Summary Of Significant Accounting Policies [Line Items]              
Equity method investments           $ 0  
Office equipment              
Summary Of Significant Accounting Policies [Line Items]              
Property and equipment, estimated useful life       3 years      
Laboratory equipment              
Summary Of Significant Accounting Policies [Line Items]              
Property and equipment, estimated useful life       5 years      
Accounts Receivable | Customer Concentration Risk              
Summary Of Significant Accounting Policies [Line Items]              
Concentration risk, percentage       100.00% 100.00%    
Revenue Benchmark | Customer Concentration Risk              
Summary Of Significant Accounting Policies [Line Items]              
Concentration risk, percentage       100.00% 100.00%    
Revenue Benchmark | Customer Concentration Risk | Collaborator One              
Summary Of Significant Accounting Policies [Line Items]              
Concentration risk, percentage       68.00% 37.00% 19.00%  
Revenue Benchmark | Customer Concentration Risk | Collaborator Two              
Summary Of Significant Accounting Policies [Line Items]              
Concentration risk, percentage       17.00% 32.00% 16.00%  
Revenue Benchmark | Customer Concentration Risk | Collaborator Three              
Summary Of Significant Accounting Policies [Line Items]              
Concentration risk, percentage       15.00% 31.00%    
Revenue Benchmark | Customer Concentration Risk | Oerth              
Summary Of Significant Accounting Policies [Line Items]              
Concentration risk, percentage           57.00%  
Maximum              
Summary Of Significant Accounting Policies [Line Items]              
Federal deposit insurance corporation premium expense       $ 250,000